The North America Glutaraldehyde Market would witness market growth of 4.3% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 67.30 Kilo Tonnes, showcasing a growth of 3.6% (2019-2022).
Glutaraldehyde, chemically known as C5H8O2, is a colorless, oily liquid with a distinct odor. It belongs to the family of dialdehydes, consisting of two aldehyde groups separated by a carbon chain of five atoms. This compound is highly reactive due to aldehyde functional groups, making it a valuable reagent in various chemical processes. One of the distinguishing characteristics of glutaraldehyde is its excellent cross-linking abilities. This property makes it a superior choice for applications where the formation of stable covalent bonds is crucial.
Stringent regulations and standards governing the use of chemicals in different applications directly impact the market. Compliance with safety and environmental regulations has become a focal point for manufacturers, influencing production processes and dynamics. Technology advancements have played a key role in enhancing the efficiency and safety of glutaraldehyde-based products. Innovations in formulation and delivery methods have improved performance and reduced environmental impact, contributing to the market's sustained growth.
According to the International Trade Administration, 2022 Canada's medical device industry size was estimated to be US$6.8 billion. The industry is expected to grow by 5.4% annually until 2028. In 2022, healthcare spending in Canada totaled approximately C$331 billion or C$8,563 per Canadian. Compliance with regulatory requirements for medical device sterilization is imperative. Glutaraldehyde's established use and regulatory approval make it a reliable option for healthcare facilities looking to meet stringent sterilization standards. Glutaraldehyde is widely utilized to sterilize medical instruments, endoscopes, and other critical devices in healthcare facilities. As a result, these aspects will boost the market growth in the coming years.
The US market dominated the North America Glutaraldehyde Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $172.4 million by 2030. The Canada market is experiencing a CAGR of 6.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.7% during (2023 - 2030).
Based on Product, the market is segmented into Glutaraldehyde 50%, Glutaraldehyde 25% and Others. Based on Application, the market is segmented into Disinfection Sterilization, Leather Tanning, Electron Light Microscopy, Pesticide and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Acuro Organics Limited, BASF SE, Lanxess AG, Neogen Corporation, Becta Laboratories, Fengchen Group Co., Ltd. (Qingdao Fengchen Technology and Trade Co., Ltd.), Hebei Guanlang Biotechnology Co., Ltd., Advanced Sterilization Products (ASP) (Fortive Corporation), Shandong Lircon Medical Technology Co., Ltd., Whiteley Corporation.
Glutaraldehyde, chemically known as C5H8O2, is a colorless, oily liquid with a distinct odor. It belongs to the family of dialdehydes, consisting of two aldehyde groups separated by a carbon chain of five atoms. This compound is highly reactive due to aldehyde functional groups, making it a valuable reagent in various chemical processes. One of the distinguishing characteristics of glutaraldehyde is its excellent cross-linking abilities. This property makes it a superior choice for applications where the formation of stable covalent bonds is crucial.
Stringent regulations and standards governing the use of chemicals in different applications directly impact the market. Compliance with safety and environmental regulations has become a focal point for manufacturers, influencing production processes and dynamics. Technology advancements have played a key role in enhancing the efficiency and safety of glutaraldehyde-based products. Innovations in formulation and delivery methods have improved performance and reduced environmental impact, contributing to the market's sustained growth.
According to the International Trade Administration, 2022 Canada's medical device industry size was estimated to be US$6.8 billion. The industry is expected to grow by 5.4% annually until 2028. In 2022, healthcare spending in Canada totaled approximately C$331 billion or C$8,563 per Canadian. Compliance with regulatory requirements for medical device sterilization is imperative. Glutaraldehyde's established use and regulatory approval make it a reliable option for healthcare facilities looking to meet stringent sterilization standards. Glutaraldehyde is widely utilized to sterilize medical instruments, endoscopes, and other critical devices in healthcare facilities. As a result, these aspects will boost the market growth in the coming years.
The US market dominated the North America Glutaraldehyde Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $172.4 million by 2030. The Canada market is experiencing a CAGR of 6.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.7% during (2023 - 2030).
Based on Product, the market is segmented into Glutaraldehyde 50%, Glutaraldehyde 25% and Others. Based on Application, the market is segmented into Disinfection Sterilization, Leather Tanning, Electron Light Microscopy, Pesticide and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Acuro Organics Limited, BASF SE, Lanxess AG, Neogen Corporation, Becta Laboratories, Fengchen Group Co., Ltd. (Qingdao Fengchen Technology and Trade Co., Ltd.), Hebei Guanlang Biotechnology Co., Ltd., Advanced Sterilization Products (ASP) (Fortive Corporation), Shandong Lircon Medical Technology Co., Ltd., Whiteley Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Product (Volume, Kilo Tonnes, USD Million, 2019-2030)
- Glutaraldehyde 50%
- Glutaraldehyde 25%
- Others
By Application (Volume, Kilo Tonnes, USD Million, 2019-2030)
- Disinfection Sterilization
- Leather Tanning
- Electron Light Microscopy
- Pesticide
- Others
By Country (Volume, Kilo Tonnes, USD Million, 2019-2030)
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Acuro Organics Limited
- BASF SE
- Lanxess AG
- Neogen Corporation
- Becta Laboratories
- Fengchen Group Co., Ltd. (Qingdao Fengchen Technology and Trade Co., Ltd.)
- Hebei Guanlang Biotechnology Co., Ltd.
- Advanced Sterilization Products (ASP) (Fortive Corporation)
- Shandong Lircon Medical Technology Co., Ltd.
- Whiteley Corporation
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Glutaraldehyde Market by Product
Chapter 5. North America Glutaraldehyde Market by Application
Chapter 6. North America Glutaraldehyde Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Acuro Organics Limited
- BASF SE
- Lanxess AG
- Neogen Corporation
- Becta Laboratories
- Fengchen Group Co., Ltd. (Qingdao Fengchen Technology and Trade Co., Ltd.)
- Hebei Guanlang Biotechnology Co., Ltd.
- Advanced Sterilization Products (ASP) (Fortive Corporation)
- Shandong Lircon Medical Technology Co., Ltd.
- Whiteley Corporation
Methodology
LOADING...
